TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...
HLD-0915 has received FDA fast track designation for mCRPC, expediting its development and review process to address unmet medical needs. Halda Therapeutics is conducting a phase 1/2 clinical trial to ...
(BPT) – Over half of all men over the age of 50 will experience frequent urination. [1] While this condition may be an entirely normal part of aging, it can leave many feeling frustrated. Many men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback